CoChat

Activation of hypoxia signaling induces phenotypic transformation of glioma cells: implications for bevacizumab antiangiogenic therapy

Open access
Xu, Hui, Rahimpour, Shervin, Nesvick, Cody L., Zhang, Xu, Ma, Jingyun, Zhang, Min, Zhang, Ge, Wang, Li, Yang, Chunzhang, Hong, Christopher S., Germanwala, Anand V., Elder, J. Bradley, Ray-Chaudhury, Abhik, Yao, Yu, Gilbert, Mark R., Lonser, Russell R., Heiss, John D., Brady, Roscoe O., Mao, Ying, Qin, Jianhua, Zhuang, Zhengping · 2015 · Oncotarget
Cited by 91

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

// Hui Xu 1 , Shervin Rahimpour 2 , Cody L. Nesvick 2 , Xu Zhang 1 , Jingyun Ma 1 , Min Zhang 1 , Ge Zhang 3 , Li Wang 1 , Chunzhang Yang 2 , Christopher S. Hong 2 , Anand V. Germanwala 4 , J. Bradley Elder 5 , Abhik Ray-Chaudhury 2 , Yu Yao 6 , Mark R. Gilbert 7 , Russell R. Lonser 5 , John D. Heiss 2 , Roscoe O. Brady 2 , Ying Mao 6 , Jianhua Qin 1 and Zhengping Zhuang 2 1 Division of Biotechnology, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, China 2 Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, Bethesda, Maryland, USA 3 Department of Immunology, Dalian Medical University, Dalian, China 4 Department of Neurological Surgery, Loyola University Medical Center, Chicago, Illinois, USA 5 Department of Neurological Surgery, The Ohio State University Medical Center, Columbus, Ohio, USA 6 Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China 7 Department of Neuro-Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA Correspondence to: Ying Mao, email: // Jianhua Qin, email: // Zhengping Zhuang, email: // Keywords : glioblastoma, bevacizumab, epithelial-mesenchymal transition, pathologic angiogenesis, hypoxia-inducible factor Received : February 12, 2015 Accepted : February 19, 2015 Published : March 14, 2015 Abstract Glioblastoma (GBM) is the most common and deadly primary brain tumor in adults. Bevacizumab, a humanized monoclonal antibody against vascular endothelial growth factor (VEGF), can attenuate tumor-associated edema and improve patient symptoms but based on magnetic resonance imaging, is associated with non-enhancing tumor progression and possibly gliosarcoma differentiation. To gain insight into these findings, we investigated the role of hypoxia and epithelial-mesenchymal transition (EMT)-associated proteins in GBM. Tumor markers of hypoxia and EMT were upregulated in bevacizumab-treated tumors from GBM patients compared to untreated counterparts. Exposure of glioma cells to 1% oxygen tension increased cell proliferation, expression of EMT-associated proteins and enhanced cell migration in vitro . These phenotypic changes were significantly attenuated by pharmacologic knockdown of hypoxia-inducible Factor 1α (HIF1α) or HIF2α, indicating that HIFs represent a therapeutic target for mesenchymal GBM cells. These findings provide insights into potential development of novel therapeutic targeting of angiogenesis-specific pathways in GBM.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.3592

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 91

Metadata

Authors
Xu, H., Rahimpour, S., Nesvick, C. L., Zhang, X., Ma, J., Zhang, M., Zhang, G., Wang, L., Yang, C., Hong, C. S., Germanwala, A. V., Elder, J. B., Ray-Chaudhury, A., Yao, Y., Gilbert, M. R., Lonser, R. R., Heiss, J. D., Brady, R. O., Mao, Y., Qin, J., & Zhuang, Z.
Venue
Oncotarget
Published
2015-03-14
Volume
6
Issue
14
Pages
11882-11893
ISSN
1949-2553 (ISSN-L)
OpenAlex
W1536103630
Cited by
91
References
10
FWCI
5.54
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Activation of hypoxia signaling induces phenotypic transformation of glioma cells: implications for bevacizumab antiangiogenic therapy. https://app.cochat.ai/papers/10.18632/oncotarget.3592
The paper
Xu, H., Rahimpour, S., Nesvick, C. L., Zhang, X., Ma, J., Zhang, M., Zhang, G., Wang, L., Yang, C., Hong, C. S., Germanwala, A. V., Elder, J. B., Ray-Chaudhury, A., Yao, Y., Gilbert, M. R., Lonser, R. R., Heiss, J. D., Brady, R. O., Mao, Y., . . . Zhuang, Z. (2015). Activation of hypoxia signaling induces phenotypic transformation of glioma cells: implications for bevacizumab antiangiogenic therapy. Oncotarget. https://doi.org/10.18632/oncotarget.3592

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.